Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Lymphomas”

464 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 464 results

Not applicableStudy completedNCT00552825
What this trial is testing

Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloblastic LeukemiaSolid Tumors,+2 more
Sheba Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00036023
What this trial is testing

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Who this might be right for
LymphomaBreast NeoplasmsLung Neoplasms+2 more
Amgen
Not applicableWithdrawnNCT02458482
What this trial is testing

Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children

Who this might be right for
Asthma
Vanderbilt University Medical Center
Testing effectiveness (Phase 2)Study completedNCT03365791
What this trial is testing

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Who this might be right for
Small Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more
Novartis Pharmaceuticals 76
Testing effectiveness (Phase 2)Study completedNCT03543813
What this trial is testing

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Who this might be right for
Solid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 133
Not applicableLooking for participantsNCT06070961
What this trial is testing

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 56
Not applicableStudy completedNCT02844842
What this trial is testing

Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Who this might be right for
Allergic RhinitisRhinoconjunctivitisAsthma
Roxall Medicina España S.A 152
Large-scale testing (Phase 3)UnknownNCT03745261
What this trial is testing

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Henan University of Traditional Chinese Medicine 240
Not applicableStudy completedNCT00601146
What this trial is testing

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease

Who this might be right for
Lung Cancer
Dana-Farber Cancer Institute 39
Not applicableNot Yet RecruitingNCT07286539
What this trial is testing

Precision Physical Exercise for Personalized Onco-Hematology.

Who this might be right for
Hematologic CancerColon CancerBreast Cancer+3 more
University of Salamanca 150
Not applicableWithdrawnNCT03161613
What this trial is testing

Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico

Who this might be right for
Multiple Indications Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT01490632
What this trial is testing

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
PsoriasisSkin DiseasesSkin Diseases, Papulosquamous
Eli Lilly and Company 271
Not applicableEnded earlyNCT04072393
What this trial is testing

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers

Who this might be right for
Lung CancerEsophageal CancerThoracic Cancer+6 more
Washington University School of Medicine 24
Not applicableStudy completedNCT03271554
What this trial is testing

Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 355
Not applicableStudy completedNCT01459653
What this trial is testing

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Who this might be right for
Febrile NeutropeniaCancerBreast Cancer+6 more
Sandoz 1,496
Early research (Phase 1)Study completedNCT03884556
What this trial is testing

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Who this might be right for
Solid TumorLymphoma
Trishula Therapeutics, Inc. 56
Testing effectiveness (Phase 2)UnknownNCT04056572
What this trial is testing

Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib

Who this might be right for
ALK-positive NSCLC
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 135
Not applicableStudy completedNCT05827341
What this trial is testing

A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials

Who this might be right for
Malignant LymphomaClinical TrialCOVID-19
Sun Yat-sen University 110
Large-scale testing (Phase 3)Active Not RecruitingNCT04904536
What this trial is testing

Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy

Who this might be right for
Neurocognitive Impairment, Mild
The George Institute 190
Early research (Phase 1)Ended earlyNCT04803227
What this trial is testing

Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19

Who this might be right for
Covid19
Histogen 13
Load More Results